Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States
Authors:
Open Access
- 1 February 2013
- journal article
- Published by Taylor & Francis in ClinicoEconomics and Outcomes Research
- Vol. 5, 101-8
Abstract
Peer reviewed article authored by (Khorana AA, Dalal MR, Lin J, Connolly GC). Read article or submit your manuscript for publishing.Keywords
This publication has 37 references indexed in Scilit:
- Epidemiology and pathophysiology of cancer-associated thrombosisBritish Journal of Cancer, 2010
- Assessing Risk of Venous Thromboembolism in the Patient With CancerJournal of Clinical Oncology, 2009
- The Link Between Cancer and Venous ThromboembolismAmerican Journal of Clinical Oncology, 2009
- Prevention of Venous ThromboembolismChest, 2008
- American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With CancerJournal of Clinical Oncology, 2007
- The prothrombotic state in cancer: pathogenic mechanismsCritical Reviews in Oncology/Hematology, 2004
- Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosisBlood, 2002
- Cancer and the prothrombotic stateThe Lancet Oncology, 2002
- Risk Factors for Deep Vein Thrombosis and Pulmonary EmbolismArchives of internal medicine (1960), 2000
- Rates of Initial and Recurrent Thromboembolic Disease Among Patients with Malignancy Versus Those without Malignancy: Risk Analysis Using Medicare Claims DataMedicine, 1999